Detalhe da pesquisa
1.
Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy.
J Cell Sci
; 128(12): 2236-48, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25956888
2.
Rescue of cell cycle progression in BRAFV600E inhibitor-resistant human melanoma by a chromatin modifier.
Tumour Biol
; 39(9): 1010428317721620, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28936920
3.
Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.
Int J Cancer
; 133(10): 2315-24, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23681936
4.
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
Blood
; 115(7): 1461-71, 2010 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008303
5.
MPM: A knowledge-based functional model of medical practice.
J Biomed Inform
; 46(3): 379-87, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23420015
6.
Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.
Cancers (Basel)
; 10(6)2018 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29904021
7.
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor).
Cancers (Basel)
; 10(6)2018 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29795041
8.
Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor.
Am J Clin Exp Immunol
; 3(1): 43-56, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24660121
9.
Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1.
PLoS One
; 7(10): e47226, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23071766
10.
ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells.
Cancer Res
; 70(11): 4676-86, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20484033
11.
Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
Cancer Res
; 70(3): 948-56, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20103648
12.
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.
Int J Biochem Cell Biol
; 41(4): 800-10, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18775505
13.
Circumvention of drug-resistance via decitabine-mediated DNMT1 depletion.
Epigenomics
; 5(3): 253-54, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303552
14.
Epigenetic fine-tuning of NF-κB-Sox9 circuitry in cancer stem cells.
Epigenomics
; 5(4): 363-64, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303554
15.
Regulation of the apoptotic activity of the ING member of histone acetyltransferase and deacetylase complexes.
Epigenomics
; 5(4): 364, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303555
16.
Prevalence of DNA methyltransferase in breast cancer by SNP analysis.
Epigenomics
; 5(4): 365, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303556
17.
Epigenetic regulation of retinoic acid susceptibility in leukemia.
Epigenomics
; 5(4): 365-66, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303557
18.
Epigenetic biomarker of metastatic melanoma.
Epigenomics
; 5(4): 366, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303558
19.
Epigenetic regulation of melanoma tumor suppressor miRNA-124a.
Epigenomics
; 5(3): 251-52, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303550
20.
Role of miR-18b/MDM2/p53 circuitry in melanoma progression.
Epigenomics
; 5(3): 254, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24303553